Skip to main content

Want a detailed portfolio tracker?

Nutriband (NTRB) P/E (2017 - 2026)

Nutriband (NTRB) P/E from Nov 30, 2017 to Jul 20, 2026. The TTM Nutriband (NTRB) P/E is -4.62. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Nutriband (NTRB)

YearP/EChange
2026-4.62+12.81%
2025-4.10-32.63%
2024-6.08+51.89%
2023-4.01-19.89%
2022-5.00-84.00%
2021-31.25-45.66%
2020-57.50+73.41%
2019-33.16-4.20%
2018-34.61-70.37%
2017-116.81N/A

Comparison Nutriband (NTRB) P/E with competitors

Nutriband (NTRB) P/E is -4.62.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.09%
ENLVEnlivex Ltd0.07-101.62%
FGENFibroGen Inc0.24-105.19%
CHRSCoherus Biosciences Inc0.85-118.35%
FBIOFortress Biotech Inc0.95-120.52%
ORMPOramed Pharmaceuticals Inc1.50-132.51%
AGENAgenus Inc3.01-165.09%
INVAInnoviva Inc3.15-168.21%
VXRTVaxart Inc3.55-176.77%
CRMDCorMedix Inc3.63-178.47%
CVACCureVac N.V.4.45-196.14%
GLPGGalapagos NV4.86-205.08%
SRPTSarepta Therapeutics Inc4.88-205.58%
ABEOAbeona Therapeutics Inc5.39-216.51%
ABUSArbutus Biopharma Corp5.60-221.01%
ZVRAZevra Therapeutics Inc5.89-227.32%
SPROSpero Therapeutics Inc6.23-234.70%
CGENCompugen Ltd6.31-236.55%
RIGLRigel Pharmaceuticals6.87-248.62%
SLXNSilexion Therapeutics Corp7.30-257.79%
OMEROmeros Corporation9.26-300.23%
AUPHAurinia Pharmaceuticals Inc9.58-307.29%
PLXProtalix BioTherapeutics Inc10.89-335.53%
ACADAcadia Pharmaceuticals Inc11.73-353.65%
TBPHTheravance Biopharma Inc12.26-365.19%
ADMAAdma Biologics Inc12.42-368.56%
HRMYHarmony Biosciences Holdings Inc13.82-398.88%
SABSSAB Biotherapeutics Inc14.14-405.71%
NAGENiagen Bioscience Inc14.82-420.46%
INCYIncyte Corp15.82-442.18%
REGNRegeneron Pharmaceuticals Inc15.86-442.92%
PBYIPuma Biotechnology Inc17.32-474.48%
CPRXCatalyst Pharmaceuticals Inc17.44-477.15%
EXELExelixis Inc17.54-479.28%
TGTXTG Therapeutics Inc18.97-510.17%
MDXGMimedx Group Inc20.55-544.48%
XOMAXOMA Royalty Corp22.87-594.71%
ARGXArgen X SE24.30-625.49%
CTMXCytomX Therapeutics Inc24.82-636.81%
XOMAOXOMA Royalty Corp25.34-648.13%
HALOHalozyme Therapeutics Inc25.62-654.16%
XOMAPXOMA Royalty Corp25.67-655.17%
VRTXVertex Pharmaceuticals Inc27.99-705.44%
RPRXRoyalty Pharma plc - Class A28.69-720.42%
SLNOSoleno Therapeutics Inc29.02-727.51%
ASNDAscendis Pharma A/S30.09-750.66%
LGNDLigand Pharmaceuticals Inc - Class B37.91-919.92%
APLSApellis Pharmaceuticals Inc39.02-943.91%
BMRNBiomarin Pharmaceutical Inc42.21-1012.91%
KRYSKrystal Biotech Inc45.34-1080.64%
ONCBeiGene Ltd69.54-1603.95%
PHARPharming Group N.V.75.03-1722.58%
TECHBio-Techne Corp101.96-2305.05%
VCELVericel Corp109.92-2477.27%
ALNYAlnylam Pharmaceuticals Inc117.96-2651.23%
GMABGenmab140.29-3134.07%
TLXTelix Pharmaceuticals Ltd162.15-3606.88%
CORTCorcept Therapeutics Inc212.86-4703.46%